441 related articles for article (PubMed ID: 33034709)
1. Long-term effects of empagliflozin on excitation-contraction-coupling in human induced pluripotent stem cell cardiomyocytes.
Pabel S; Reetz F; Dybkova N; Shomroni O; Salinas G; Mustroph J; Hammer KP; Hasenfuss G; Hamdani N; Maier LS; Streckfuss-Bömeke K; Sossalla S
J Mol Med (Berl); 2020 Dec; 98(12):1689-1700. PubMed ID: 33034709
[TBL] [Abstract][Full Text] [Related]
2. Empagliflozin reduces Ca/calmodulin-dependent kinase II activity in isolated ventricular cardiomyocytes.
Mustroph J; Wagemann O; Lücht CM; Trum M; Hammer KP; Sag CM; Lebek S; Tarnowski D; Reinders J; Perbellini F; Terracciano C; Schmid C; Schopka S; Hilker M; Zausig Y; Pabel S; Sossalla ST; Schweda F; Maier LS; Wagner S
ESC Heart Fail; 2018 Aug; 5(4):642-648. PubMed ID: 30117720
[TBL] [Abstract][Full Text] [Related]
3. Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human iPSC-Derived Cardiomyocytes.
Ng KM; Lau YM; Dhandhania V; Cai ZJ; Lee YK; Lai WH; Tse HF; Siu CW
Sci Rep; 2018 Oct; 8(1):14872. PubMed ID: 30291295
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic basis of excitation-contraction coupling in human pluripotent stem cell-derived ventricular cardiomyocytes revealed by Ca2+ spark characteristics: direct evidence of functional Ca2+-induced Ca2+ release.
Li S; Cheng H; Tomaselli GF; Li RA
Heart Rhythm; 2014 Jan; 11(1):133-40. PubMed ID: 24096168
[TBL] [Abstract][Full Text] [Related]
5. Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure.
Gherghiceanu M; Barad L; Novak A; Reiter I; Itskovitz-Eldor J; Binah O; Popescu LM
J Cell Mol Med; 2011 Nov; 15(11):2539-51. PubMed ID: 21883888
[TBL] [Abstract][Full Text] [Related]
6. Empagliflozin reduces arrhythmogenic effects in rat neonatal and human iPSC-derived cardiomyocytes and improves cytosolic calcium handling at least partially independent of NHE1.
Silva Dos Santos D; Turaça LT; Coutinho KCDS; Barbosa RAQ; Polidoro JZ; Kasai-Brunswick TH; Campos de Carvalho AC; Girardi ACC
Sci Rep; 2023 May; 13(1):8689. PubMed ID: 37248416
[TBL] [Abstract][Full Text] [Related]
7. Integrins Increase Sarcoplasmic Reticulum Activity for Excitation-Contraction Coupling in Human Stem Cell-Derived Cardiomyocytes.
Wang BX; Kane C; Nicastro L; King O; Kit-Anan W; Downing B; Deidda G; Couch LS; Pinali C; Mitraki A; MacLeod KT; Terracciano CM
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142853
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells.
Kim JJ; Yang L; Lin B; Zhu X; Sun B; Kaplan AD; Bett GC; Rasmusson RL; London B; Salama G
J Mol Cell Cardiol; 2015 Apr; 81():81-93. PubMed ID: 25644533
[TBL] [Abstract][Full Text] [Related]
9. Polydatin modulates Ca(2+) handling, excitation-contraction coupling and β-adrenergic signaling in rat ventricular myocytes.
Deng J; Liu W; Wang Y; Dong M; Zheng M; Liu J
J Mol Cell Cardiol; 2012 Nov; 53(5):646-56. PubMed ID: 22921781
[TBL] [Abstract][Full Text] [Related]
10. Local control of excitation-contraction coupling in human embryonic stem cell-derived cardiomyocytes.
Zhu WZ; Santana LF; Laflamme MA
PLoS One; 2009; 4(4):e5407. PubMed ID: 19404384
[TBL] [Abstract][Full Text] [Related]
11. Empagliflozin improves left ventricular diastolic function of db/db mice.
Moellmann J; Klinkhammer BM; Droste P; Kappel B; Haj-Yehia E; Maxeiner S; Artati A; Adamski J; Boor P; Schütt K; Lopaschuk GD; Verma S; Marx N; Lehrke M
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165807. PubMed ID: 32353614
[TBL] [Abstract][Full Text] [Related]
12. Optical Investigation of Action Potential and Calcium Handling Maturation of hiPSC-Cardiomyocytes on Biomimetic Substrates.
Pioner JM; Santini L; Palandri C; Martella D; Lupi F; Langione M; Querceto S; Grandinetti B; Balducci V; Benzoni P; Landi S; Barbuti A; Ferrarese Lupi F; Boarino L; Sartiani L; Tesi C; Mack DL; Regnier M; Cerbai E; Parmeggiani C; Poggesi C; Ferrantini C; Coppini R
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382622
[TBL] [Abstract][Full Text] [Related]
13. Thyroid and Glucocorticoid Hormones Promote Functional T-Tubule Development in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Parikh SS; Blackwell DJ; Gomez-Hurtado N; Frisk M; Wang L; Kim K; Dahl CP; Fiane A; Tønnessen T; Kryshtal DO; Louch WE; Knollmann BC
Circ Res; 2017 Dec; 121(12):1323-1330. PubMed ID: 28974554
[TBL] [Abstract][Full Text] [Related]
14. Dantrolene suppresses spontaneous Ca2+ release without altering excitation-contraction coupling in cardiomyocytes of aged mice.
Domeier TL; Roberts CJ; Gibson AK; Hanft LM; McDonald KS; Segal SS
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(6):H818-29. PubMed ID: 25038147
[TBL] [Abstract][Full Text] [Related]
15. Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats.
Lee TI; Chen YC; Lin YK; Chung CC; Lu YY; Kao YH; Chen YJ
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987285
[TBL] [Abstract][Full Text] [Related]
16. Reduction of SR Ca
Neef S; Mann C; Zwenger A; Dybkova N; Maier LS
Basic Res Cardiol; 2017 Jul; 112(4):45. PubMed ID: 28612156
[TBL] [Abstract][Full Text] [Related]
17. Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations.
Novak A; Barad L; Lorber A; Gherghiceanu M; Reiter I; Eisen B; Eldor L; Itskovitz-Eldor J; Eldar M; Arad M; Binah O
J Cell Mol Med; 2015 Aug; 19(8):2006-18. PubMed ID: 26153920
[TBL] [Abstract][Full Text] [Related]
18. A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.
Preininger MK; Jha R; Maxwell JT; Wu Q; Singh M; Wang B; Dalal A; Mceachin ZT; Rossoll W; Hales CM; Fischbach PS; Wagner MB; Xu C
Dis Model Mech; 2016 Sep; 9(9):927-39. PubMed ID: 27491078
[TBL] [Abstract][Full Text] [Related]
19. Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction.
Connelly KA; Zhang Y; Desjardins JF; Nghiem L; Visram A; Batchu SN; Yerra VG; Kabir G; Thai K; Advani A; Gilbert RE
Cardiovasc Diabetol; 2020 Feb; 19(1):13. PubMed ID: 32035482
[TBL] [Abstract][Full Text] [Related]
20. Empagliflozin attenuates doxorubicin-induced cardiotoxicity by inhibiting the JNK signaling pathway.
Chang HY; Hsu HC; Fang YH; Liu PY; Liu YW
Biomed Pharmacother; 2024 Jul; 176():116759. PubMed ID: 38788603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
